Kennedy Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.6M	Buy	293,996 +80,195	+38%	+$6.26M	0.48%	48
2025 Q4	$16.9M	Buy	213,801 +23,414	+12%	+$2.03M	0.36%	85
2025 Q3	$17.4M	Sell	190,387 -76,643	-29%	-$6.25M	0.39%	65
2025 Q2	$17.4M	Sell	267,030 -19,746	-7%	-$1.29M	0.42%	58
2025 Q1	$19.2M	Buy	286,776 +100,501	+54%	+$6M	0.46%	44
2024 Q4	$10.3M	Sell	186,275 -2,532	-1%	-$145K	0.23%	133
2024 Q3	$11.3M	Sell	188,807 -9,247	-5%	-$564K	0.25%	118
2024 Q2	$12.6M	Sell	198,054 -11,972	-6%	-$777K	0.27%	112
2024 Q1	$14.5M	Sell	210,026 -18,928	-8%	-$1.14M	0.3%	92
2023 Q4	$12.6M	Buy	228,954 +10,882	+5%	+$599K	0.28%	108
2023 Q3	$12.7M	Sell	218,072 -91,815	-30%	-$5.3M	0.31%	89
2023 Q2	$16.7M	Buy	309,887 +27,266	+10%	+$1.21M	0.39%	55
2023 Q1	$11.2M	Sell	282,621 -77,873	-22%	-$3.28M	0.33%	79
2022 Q4	$14.5M	Buy	360,494 +18,044	+5%	+$678K	0.41%	63
2022 Q3	$11M	Buy	342,450 +180,376	+111%	+$6.17M	0.32%	92
2022 Q2	$4.81M	Buy	+162,074	New	+$4.68M	0.13%	274
2017 Q3	–	Sell	-57,115	Closed	-$2.67M	–	735
2017 Q2	$2.67M	Sell	57,115 -25,062	-30%	-$1.21M	0.05%	543
2017 Q1	$4.07M	Buy	+82,177	New	+$4.61M	0.07%	469
2016 Q2	–	Sell	-15,000	Closed	-$505K	–	708
2016 Q1	$505K	Buy	+15,000	New	+$509K	0.01%	696
2014 Q2	–	Sell	-201,231	Closed	-$6.31M	–	744
2014 Q1	$6.31M	Buy	201,231 +63,287	+46%	+$1.68M	0.12%	324
2013 Q4	$2.77M	Buy	137,944 +27,497	+25%	+$357K	0.05%	493
2013 Q3	$1.08M	Buy	+110,447	New	+$796K	0.02%	632